BrainCool AB (publ): BrainCool launches a new commercialization strategy for its breakthrough product Cooral ®System aiming for reimbursement in the U.S

BrainCool AB launches a new commercialization strategy in the U.S for the new cryotherapy product Cooral ®System supporting patients undergoing treatment for cancer.
Braincool has now created a... | May 3, 2023

Related Keywords

United States ,Japan ,American ,Braincool Martin Waleij ,American Medical Association ,International Society Of Oral Oncology ,Oncology Nursing Society ,Centers For Medicare ,American Society Of Clinical Oncology ,Medicaid Services ,Oral Oncology ,Clinical Oncology ,Government Programs ,Bral Ab Stock Exchange ,News ,Information ,Press Release ,Raincool ,Tb ,Aunches ,Few ,Ommercialization ,Strategy ,N ,The ,Or ,Cryotherapy ,Product ,Booral ,Supporting ,Patients ,Nundergoing ,Treatment ,Gas ,Dow ,Reated 0g85 Se0005731833 ,